Spironolactone and risk of incident breast cancer in women older than 55 years: Retrospective, matched cohort study

BMJ (Online)

Volumn 345, Issue 7868, 2012, Pages

  Mackenzie, Isla S ^a   MacDonald, Thomas M ^a   Thompson, Alastair ^b   Morant, Steve ^a   Wei, Li ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b Dundee Cancer Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; METFORMIN; ORAL CONTRACEPTIVE AGENT; SPIRONOLACTONE; STEROID; DIURETIC AGENT;

ADULT; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; DRUG EFFICACY; DRUG EXPOSURE; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; UNITED KINGDOM; ANIMAL; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; GENERAL PRACTICE; HEART FAILURE; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; POSTMENOPAUSE; PRACTICE GUIDELINE; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODEL; RODENT; STATISTICS;

ANIMALS; BREAST NEOPLASMS; DIURETICS; FAMILY PRACTICE; FEMALE; GREAT BRITAIN; HEART FAILURE; HUMANS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; POSTMENOPAUSE; PRACTICE GUIDELINES AS TOPIC; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; RODENTIA; SPIRONOLACTONE;

EID: 84864536183     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.e4447     Document Type: Article

References (22)

1. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, et al. The effects of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999;341:709-17. (Pubitemid 29407370)
2. NICE. Hypertension: clinical management of primary hypertension in adults. Guideline CG127. 2011. http://guidance.nice.org.uk/CG127.
3. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF, et al. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens 2004;18:139-85. (Pubitemid 38425770)
4. Anonymous. Spironolactone: no longer for hypertension. Drug Ther Bull 1988;26:88.
5. British National Formulary No 62. 2011. http://bnf.org/bnf/bnf/current/ 2371.htm? q=spironolactone&t=search&ss=text&p=1#-hit.
6. Gardiner P, Schrode K, Quinlan D, Martin BK, Boreham DR, Rogers MS, et al. Spironolactone metabolism: steady-state serum levels of the sulfur-containing metabolites. J Clin Pharmacol 1989;29:342-7. (Pubitemid 19125773)
7. Parthasarathy HK, Ménard J, White WB, Young WF Jr, Williams GH, Williams B, et al. A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism. J Hypertens 2011;29:980-90.
8. Loube SD, Quirk RA. Breast cancer associated with administration of spironolactone. Lancet 1975;1:1428-9.
9. Stierer M, Spoula H, Rosen HR. Breast cancer in the male [abstract only]. Onkologie 1990;13:128-31.
10. Selby JV, Friedman GD, Fireman BH. Screening prescription drugs for possible carcinogenicity: eleven to fifteen years of follow-up. Cancer Res 1989;49:5736-47. (Pubitemid 19256461)
11. Jick H, Armstrong B. Breast cancer and spironolactone. Lancet 1975;2:368-9.
12. Armstrong B, Stevens N, Doll R. Retrospective study of the association between use of rauwolfia derivatives and breast cancer in English women. Lancet 1974;2:672-5.
13. Boston Collaborative Drug Surveillance Program. Reserpine and breast cancer. Lancet 1974;2:669-71.
14. Danielson DA, Jick H, Hunter JR, Stergachis A, Madsen S. Nonestrogenic drugs and breast cancer. Am J Epidemiol 1982;116:329-32. (Pubitemid 12048412)
15. Shaw JC, White LE. Long-term safety of spironolactone in acne: results of an 8-year followup study. J Cutan Med Surg 2002;6:541-5. (Pubitemid 36091499)
16. Walley T, Mantgani A. The UK General Practice Research Database. Lancet 1997;350:1097-9. (Pubitemid 27437871)
17. IARC. IARC monographs, volume 79: spironolactone. P319-337. 2012. http://monographs. iarc.fr/ENG/Monographs/vol79/mono79-13.pdf.
18. Gonzalez-Perez A, Ronquist G, Rodriguez LAG. Breast cancer incidence and use of antihypertensive medication in women. Pharmacoepidemiol Drug Saf 2004;13:581-5. (Pubitemid 39214037)
19. Fryzek JP, Poulsen AH, Lipworth L, Pedersen L, Norgaard M, McLaughlin JK, et al. A cohort study of antihypertensive medication use and breast cancer among Danish women. Breast Cancer Res Treat 2006;97:231-6. (Pubitemid 43945753)
20. Largent JA, McEligot AJ, Ziogas A, Reid C, Hess J, Leighton N, et al. Hypertension, diuretics and breast cancer risk. J Hum Hypertens 2006;20:727-32. (Pubitemid 44430670)
21. Li CI, Malone KE, Weiss NS, Boudreau DM, Cushing-Haugen KL, Daling JR. Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years. Cancer 2003;98:1504-13. (Pubitemid 37151507)
22. Goon PKY, Messerli FH, Lip GYH. Hypertension and breast cancer: an association revisited? J Hum Hypertens 2006;20:722-4. (Pubitemid 44430668)